Graeme Wilkinson

1.2k total citations
27 papers, 1.0k citations indexed

About

Graeme Wilkinson is a scholar working on Molecular Biology, Physiology and Physiology. According to data from OpenAlex, Graeme Wilkinson has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Physiology and 7 papers in Physiology. Recurrent topics in Graeme Wilkinson's work include Receptor Mechanisms and Signaling (15 papers), Adenosine and Purinergic Signaling (10 papers) and Nitric Oxide and Endothelin Effects (6 papers). Graeme Wilkinson is often cited by papers focused on Receptor Mechanisms and Signaling (15 papers), Adenosine and Purinergic Signaling (10 papers) and Nitric Oxide and Endothelin Effects (6 papers). Graeme Wilkinson collaborates with scholars based in United Kingdom, United States and Canada. Graeme Wilkinson's co-authors include Michael R. Boarder, Gary B. Willars, John R. Purkiss, Tim D. Werry, Gary A. Weisman, John T. Turner, Graeme Milligan, Shirley M. Wilson, Kevin Pritchard and W. Feniuk and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Nature Reviews Drug Discovery.

In The Last Decade

Graeme Wilkinson

27 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Graeme Wilkinson United Kingdom 17 594 392 266 192 110 27 1.0k
Rhonda L. Carter United States 19 627 1.1× 265 0.7× 192 0.7× 122 0.6× 53 0.5× 33 948
Ian Dainty United Kingdom 13 409 0.7× 455 1.2× 180 0.7× 259 1.3× 27 0.2× 19 879
Normand McNicoll Canada 21 771 1.3× 72 0.2× 216 0.8× 250 1.3× 257 2.3× 34 1.4k
G. Kurt Hogaboom United States 18 515 0.9× 300 0.8× 244 0.9× 434 2.3× 30 0.3× 29 1.1k
Marc Paulais France 24 1.3k 2.2× 90 0.2× 195 0.7× 249 1.3× 61 0.6× 44 1.6k
Hisayuki Matsuo Japan 10 971 1.6× 181 0.5× 389 1.5× 105 0.5× 35 0.3× 14 1.3k
Dennis Abraham United States 18 682 1.1× 70 0.2× 194 0.7× 149 0.8× 76 0.7× 35 1.1k
Sandip Panicker United States 18 328 0.6× 94 0.2× 253 1.0× 197 1.0× 63 0.6× 40 1.1k
Angela D. Burgstahler United States 21 874 1.5× 284 0.7× 272 1.0× 105 0.5× 18 0.2× 24 1.5k
Loice H. Jeyakumar United States 17 775 1.3× 190 0.5× 165 0.6× 96 0.5× 45 0.4× 18 1000

Countries citing papers authored by Graeme Wilkinson

Since Specialization
Citations

This map shows the geographic impact of Graeme Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme Wilkinson more than expected).

Fields of papers citing papers by Graeme Wilkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme Wilkinson. The network helps show where Graeme Wilkinson may publish in the future.

Co-authorship network of co-authors of Graeme Wilkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme Wilkinson. A scholar is included among the top collaborators of Graeme Wilkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme Wilkinson. Graeme Wilkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karim, Mohd Anisul, Leo Speidel, Lisa Logie, et al.. (2023). Integrative GWAS and co-localisation analysis suggests novel genes associated with age-related multimorbidity. Scientific Data. 10(1). 655–655. 3 indexed citations
2.
Wilkinson, Graeme, et al.. (2022). Healthspan versus lifespan: new medicines to close the gap. Nature Aging. 2(11). 984–988. 10 indexed citations
3.
Simpson, Peter B. & Graeme Wilkinson. (2020). What makes a drug discovery consortium successful?. Nature Reviews Drug Discovery. 19(11). 737–738. 4 indexed citations
4.
Wilkinson, Graeme & Kevin Pritchard. (2014). In Vitro Screening for Drug Repositioning. SLAS DISCOVERY. 20(2). 167–179. 48 indexed citations
5.
Coopman, Karen, Yan Huang, Neil R. Johnston, et al.. (2010). Comparative Effects of the Endogenous Agonist Glucagon-Like Peptide-1 (GLP-1)-(7-36) Amide and the Small-Molecule Ago-Allosteric Agent “Compound 2” at the GLP-1 Receptor. Journal of Pharmacology and Experimental Therapeutics. 334(3). 795–808. 46 indexed citations
6.
Kurian, Nisha, et al.. (2009). Full and Partial Agonists of Muscarinic M3 Receptors Reveal Single and Oscillatory Ca2+ Responses by β2-Adrenoceptors. Journal of Pharmacology and Experimental Therapeutics. 330(2). 502–512. 17 indexed citations
7.
Werry, Tim D., Graeme Wilkinson, & Gary B. Willars. (2003). Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+. Biochemical Journal. 374(2). 281–296. 147 indexed citations
8.
Werry, Tim D., Graeme Wilkinson, & Gary B. Willars. (2003). Cross Talk between P2Y2 Nucleotide Receptors and CXC Chemokine Receptor 2 Resulting in Enhanced Ca2+ Signaling Involves Enhancement of Phospholipase C Activity and Is Enabled by Incremental Ca2+ Release in Human Embryonic Kidney Cells. Journal of Pharmacology and Experimental Therapeutics. 307(2). 661–669. 20 indexed citations
9.
Welsby, Philip J., Ian Carr, Graeme Wilkinson, & Graeme Milligan. (2002). Regulation of the avidity of ternary complexes containing the human 5‐HT1A receptor by mutation of a receptor contact site on the interacting G protein α subunit. British Journal of Pharmacology. 137(3). 345–352. 4 indexed citations
10.
Werry, Tim D., Mark Christie, Ian Dainty, Graeme Wilkinson, & Gary B. Willars. (2002). Ca2+ signalling by recombinant human CXCR2 chemokine receptors is potentiated by P2Y nucleotide receptors in HEK cells. British Journal of Pharmacology. 135(5). 1199–1208. 28 indexed citations
11.
12.
Wilkinson, Graeme, et al.. (1996). Potent antagonism by BIM‐23056 at the human recombinant somatostatin sst5 receptor. British Journal of Pharmacology. 118(3). 445–447. 34 indexed citations
13.
Brown, Colin A., et al.. (1996). P2 purinoceptor-stimulated conversion of arginine to citrulline in bovine endothelial cells is reduced by inhibition of protein kinase C. Biochemical Pharmacology. 52(12). 1849–1854. 16 indexed citations
14.
Boarder, Michael R., Gary A. Weisman, John T. Turner, & Graeme Wilkinson. (1995). G protein-coupled P2 purinoceptors: from molecular biology to functional responses. Trends in Pharmacological Sciences. 16(4). 133–139. 168 indexed citations
15.
Wilkinson, Graeme & Michael R. Boarder. (1995). Binding of [35S]adenosine 5′-O-(2-thiodiphosphate) to endothelial cells in culture. Biochemical Pharmacology. 49(10). 1411–1418. 7 indexed citations
16.
Purkiss, John R., Graeme Wilkinson, & Michael R. Boarder. (1994). Differential regulation of inositol 1,4,5‐trisphosphate by co‐existing P2Y‐purinoceptors and nucleotide receptors on bovine aortic endothelial cells. British Journal of Pharmacology. 111(3). 723–728. 42 indexed citations
17.
Wilkinson, Graeme, K. McKechnie, Ian Dainty, & Michael R. Boarder. (1994). P2Y purinoceptor and nucleotide receptor-induced relaxation of precontracted bovine aortic collateral artery rings: differential sensitivity to suramin and indomethacin.. Journal of Pharmacology and Experimental Therapeutics. 268(2). 881–887. 46 indexed citations
18.
Purkiss, John R., et al.. (1994). Stimulation of phospholipase C in cultured microvascular endothelial cells from human frontal lobe by histamine, endothelin and purinoceptor agonists. British Journal of Pharmacology. 111(4). 1041–1046. 14 indexed citations
19.
Purkiss, John R., Graeme Wilkinson, & Michael R. Boarder. (1993). Evidence for a nucleotide receptor on adrenal medullary endothelial cells linked to phospholipase C and phospholipase D. British Journal of Pharmacology. 108(4). 1031–1037. 22 indexed citations
20.
Wilkinson, Graeme, John R. Purkiss, & Michael R. Boarder. (1993). The regulation of aortic endothelial cells by purines and pyrimidines involves co‐existing P2y‐purinoceptors and nucleotide receptors linked to phospholipase C. British Journal of Pharmacology. 108(3). 689–693. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rhonda L. Carter Breakdown of academic impact, for papers by Ian Dainty Breakdown of academic impact, for papers by Normand McNicoll Breakdown of academic impact, for papers by G. Kurt Hogaboom Breakdown of academic impact, for papers by Marc Paulais Breakdown of academic impact, for papers by Hisayuki Matsuo Breakdown of academic impact, for papers by Dennis Abraham Breakdown of academic impact, for papers by Sandip Panicker Breakdown of academic impact, for papers by Angela D. Burgstahler Breakdown of academic impact, for papers by Loice H. Jeyakumar
Rankless by CCL
2026